These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 8083358

  • 1. Behavioral consequences of bone marrow transplantation in the treatment of murine mucopolysaccharidosis type VII.
    Bastedo L, Sands MS, Lambert DT, Pisa MA, Birkenmeier E, Chang PL.
    J Clin Invest; 1994 Sep; 94(3):1180-6. PubMed ID: 8083358
    [Abstract] [Full Text] [Related]

  • 2. Behavioural abnormalities in a murine model of a human lysosomal storage disease.
    Chang PL, Lambert DT, Pisa MA.
    Neuroreport; 1993 May; 4(5):507-10. PubMed ID: 8513128
    [Abstract] [Full Text] [Related]

  • 3. Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates.
    Sands MS, Barker JE, Vogler C, Levy B, Gwynn B, Galvin N, Sly WS, Birkenmeier E.
    Lab Invest; 1993 Jun; 68(6):676-86. PubMed ID: 8515654
    [Abstract] [Full Text] [Related]

  • 4. Enzyme replacement therapy for murine mucopolysaccharidosis type VII leads to improvements in behavior and auditory function.
    O'Connor LH, Erway LC, Vogler CA, Sly WS, Nicholes A, Grubb J, Holmberg SW, Levy B, Sands MS.
    J Clin Invest; 1998 Apr 01; 101(7):1394-400. PubMed ID: 9525982
    [Abstract] [Full Text] [Related]

  • 5. Bone marrow transplantation has a significant effect on enzyme levels and storage of glycosaminoglycans in tissues and in isolated hepatocytes of mucopolysaccharidosis type VII mice.
    Poorthuis BJ, Romme AE, Willemsen R, Wagemaker G.
    Pediatr Res; 1994 Aug 01; 36(2):187-93. PubMed ID: 7970933
    [Abstract] [Full Text] [Related]

  • 6. Brain transplantation of genetically modified bone marrow stromal cells corrects CNS pathology and cognitive function in MPS VII mice.
    Sakurai K, Iizuka S, Shen JS, Meng XL, Mori T, Umezawa A, Ohashi T, Eto Y.
    Gene Ther; 2004 Oct 01; 11(19):1475-81. PubMed ID: 15295619
    [Abstract] [Full Text] [Related]

  • 7. Syngeneic bone marrow transplantation reduces the hearing loss associated with murine mucopolysaccharidosis type VII.
    Sands MS, Erway LC, Vogler C, Sly WS, Birkenmeier EH.
    Blood; 1995 Sep 01; 86(5):2033-40. PubMed ID: 7655032
    [Abstract] [Full Text] [Related]

  • 8. Brain transplantation of genetically engineered human neural stem cells globally corrects brain lesions in the mucopolysaccharidosis type VII mouse.
    Meng XL, Shen JS, Ohashi T, Maeda H, Kim SU, Eto Y.
    J Neurosci Res; 2003 Oct 15; 74(2):266-77. PubMed ID: 14515356
    [Abstract] [Full Text] [Related]

  • 9. Disappearance of lysosomal storage in spleen and liver of mucopolysaccharidosis VII mice after transplantation of genetically modified bone marrow cells.
    Maréchal V, Naffakh N, Danos O, Heard JM.
    Blood; 1993 Aug 15; 82(4):1358-65. PubMed ID: 8353294
    [Abstract] [Full Text] [Related]

  • 10. Lentiviral-mediated gene therapy results in sustained expression of β-glucuronidase for up to 12 months in the gus(mps/mps) and up to 18 months in the gus(tm(L175F)Sly) mouse models of mucopolysaccharidosis type VII.
    Derrick-Roberts AL, Pyragius CE, Kaidonis XM, Jackson MR, Anson DS, Byers S.
    Hum Gene Ther; 2014 Sep 15; 25(9):798-810. PubMed ID: 25003807
    [Abstract] [Full Text] [Related]

  • 11. Nonablative neonatal marrow transplantation attenuates functional and physical defects of beta-glucuronidase deficiency.
    Soper BW, Lessard MD, Vogler CA, Levy B, Beamer WG, Sly WS, Barker JE.
    Blood; 2001 Mar 01; 97(5):1498-504. PubMed ID: 11222399
    [Abstract] [Full Text] [Related]

  • 12. Somatic gene therapy for a neurodegenerative disease using microencapsulated recombinant cells.
    Ross CJ, Ralph M, Chang PL.
    Exp Neurol; 2000 Dec 01; 166(2):276-86. PubMed ID: 11085893
    [Abstract] [Full Text] [Related]

  • 13. Correction of murine mucopolysaccharidosis VII by a human beta-glucuronidase transgene.
    Kyle JW, Birkenmeier EH, Gwynn B, Vogler C, Hoppe PC, Hoffmann JW, Sly WS.
    Proc Natl Acad Sci U S A; 1990 May 01; 87(10):3914-8. PubMed ID: 2111021
    [Abstract] [Full Text] [Related]

  • 14. Murine mucopolysaccharidosis type VII. Characterization of a mouse with beta-glucuronidase deficiency.
    Birkenmeier EH, Davisson MT, Beamer WG, Ganschow RE, Vogler CA, Gwynn B, Lyford KA, Maltais LM, Wawrzyniak CJ.
    J Clin Invest; 1989 Apr 01; 83(4):1258-66. PubMed ID: 2495302
    [Abstract] [Full Text] [Related]

  • 15. Treatment of a lysosomal storage disease, mucopolysaccharidosis VII, with microencapsulated recombinant cells.
    Ross CJ, Bastedo L, Maier SA, Sands MS, Chang PL.
    Hum Gene Ther; 2000 Oct 10; 11(15):2117-27. PubMed ID: 11044913
    [Abstract] [Full Text] [Related]

  • 16. Increased life span and correction of metabolic defects in murine mucopolysaccharidosis type VII after syngeneic bone marrow transplantation.
    Birkenmeier EH, Barker JE, Vogler CA, Kyle JW, Sly WS, Gwynn B, Levy B, Pegors C.
    Blood; 1991 Dec 01; 78(11):3081-92. PubMed ID: 1954394
    [Abstract] [Full Text] [Related]

  • 17. Enzyme replacement in murine mucopolysaccharidosis type VII: neuronal and glial response to beta-glucuronidase requires early initiation of enzyme replacement therapy.
    Vogler C, Levy B, Galvin NJ, Thorpe C, Sands MS, Barker JE, Baty J, Birkenmeier EH, Sly WS.
    Pediatr Res; 1999 Jun 01; 45(6):838-44. PubMed ID: 10367775
    [Abstract] [Full Text] [Related]

  • 18. Murine mucopolysaccharidosis type VII: long term therapeutic effects of enzyme replacement and enzyme replacement followed by bone marrow transplantation.
    Sands MS, Vogler C, Torrey A, Levy B, Gwynn B, Grubb J, Sly WS, Birkenmeier EH.
    J Clin Invest; 1997 Apr 01; 99(7):1596-605. PubMed ID: 9120003
    [Abstract] [Full Text] [Related]

  • 19. Enzyme replacement therapy for murine mucopolysaccharidosis type VII.
    Sands MS, Vogler C, Kyle JW, Grubb JH, Levy B, Galvin N, Sly WS, Birkenmeier EH.
    J Clin Invest; 1994 Jun 01; 93(6):2324-31. PubMed ID: 8200966
    [Abstract] [Full Text] [Related]

  • 20. Widespread biochemical correction of murine mucopolysaccharidosis type VII pathology by liver hydrodynamic plasmid delivery.
    Richard M, Arfi A, Seguin J, Gandolphe C, Scherman D.
    Gene Ther; 2009 Jun 01; 16(6):746-56. PubMed ID: 19357715
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.